Rémy Hanf

3.5k total citations
31 papers, 1.3k citations indexed

About

Rémy Hanf is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Rémy Hanf has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Rémy Hanf's work include Liver Disease Diagnosis and Treatment (10 papers), Ion channel regulation and function (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Rémy Hanf is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Ion channel regulation and function (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Rémy Hanf collaborates with scholars based in France, United States and Germany. Rémy Hanf's co-authors include Bart Staels, Dean W. Hum, A. Rubenstrunk, Bertrand Cariou, Benoît Noël, J.C. Fruchart, Anne Tailleux, Morgane Baron, Lesley J. Millatt and Rodolphe Fischmeister and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Diabetes Care.

In The Last Decade

Rémy Hanf

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rémy Hanf France	14	675	611	296	254	217	31	1.3k
C. Candelaresi Italy	20	587 0.9×	952 1.6×	505 1.7×	478 1.9×	488 2.2×	31	1.8k
Prasanna K. Santhekadur India	23	994 1.5×	784 1.3×	283 1.0×	222 0.9×	226 1.0×	57	2.1k
Yaxi Chen China	18	867 1.3×	565 0.9×	197 0.7×	177 0.7×	283 1.3×	50	1.9k
Pierre‐Damien Denechaud France	17	1.2k 1.7×	609 1.0×	384 1.3×	111 0.4×	552 2.5×	27	2.0k
Jamie E. Mells United States	10	447 0.7×	987 1.6×	675 2.3×	205 0.8×	464 2.1×	11	1.5k
Patricia Aspichueta Spain	21	585 0.9×	778 1.3×	366 1.2×	160 0.6×	217 1.0×	51	1.5k
Raquel Fucho Spain	14	622 0.9×	682 1.1×	183 0.6×	97 0.4×	144 0.7×	25	1.5k
María E. Miquilena-Colina Spain	14	449 0.7×	1.0k 1.7×	361 1.2×	178 0.7×	227 1.0×	16	1.5k
Inmaculada García‐Ruiz Spain	19	510 0.8×	508 0.8×	159 0.5×	141 0.6×	117 0.5×	35	1.2k
Hélène Dehondt France	15	518 0.8×	280 0.5×	207 0.7×	70 0.3×	326 1.5×	18	1.1k

Countries citing papers authored by Rémy Hanf

Since Specialization

Citations

This map shows the geographic impact of Rémy Hanf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rémy Hanf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rémy Hanf more than expected).

Fields of papers citing papers by Rémy Hanf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rémy Hanf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rémy Hanf. The network helps show where Rémy Hanf may publish in the future.

Co-authorship network of co-authors of Rémy Hanf

This figure shows the co-authorship network connecting the top 25 collaborators of Rémy Hanf. A scholar is included among the top collaborators of Rémy Hanf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rémy Hanf. Rémy Hanf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bobowski, Marie, Philippe Delataille, Rémy Hanf, et al.. (2024). WED-105 Nitazoxanide directly protects from stress-induced cell death to alleviate liver damage in preclinical models of acute-on-chronic liver failure. Journal of Hepatology. 80. S191–S191. 1 indexed citations

Schattenberg, Jörn M., Albert Parés, Kris V. Kowdley, et al.. (2021). A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA. Journal of Hepatology. 74(6). 1344–1354. 125 indexed citations

Chávez‐Talavera, Oscar, Matthieu Wargny, Matthieu Pichelin, et al.. (2019). Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes. Metabolism. 103. 154042–154042. 33 indexed citations

Hanf, Rémy, Pierre Chaumat, Zouher Majd, et al.. (2019). SAT-299-Assessment of NIS4 clinical utility for identification of patients with active NASH (NAS ≥ 4) and significant fibrosis (F ≥ 2) in patients at risk of NASH. Journal of Hepatology. 70(1). e770–e770. 2 indexed citations

Sanyal, A., John Brozek, A. Roudot, et al.. (2016). A New Method including the Quantification of Circulating Mirnas Allows the Efficient Identification of Nash Patients at Risk who should be Treated. Journal of Hepatology. 64(2). S717–S717. 1 indexed citations

Ratziu, Vlad, S. Harrison, A. Sanyal, et al.. (2016). PLPNA3 Status in Nash is Associated with Increased Histological Severity at Baseline but Not with Response to Therapy in the Golden-505 Elafibranor Trial. Journal of Hepatology. 64(2). S147–S147.

Hanf, Rémy, Lesley J. Millatt, Bertrand Cariou, et al.. (2014). The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma–associated adverse cardiac effects. Diabetes and Vascular Disease Research. 11(6). 440–447. 34 indexed citations

Staels, Bart, A. Rubenstrunk, Benoît Noël, et al.. (2013). Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology. 58(6). 1941–1952. 350 indexed citations

Briand, Olivier, Véronique Touche, Kristiaan Wouters, et al.. (2012). Activation of intestinal peroxisome proliferator-activated receptor- increases high-density lipoprotein production. European Heart Journal. 34(32). 2566–2574. 52 indexed citations

10.

Rubenstrunk, A., Rémy Hanf, Dean W. Hum, J.C. Fruchart, & Bart Staels. (2007). Safety issues and prospects for future generations of PPAR modulators. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1771(8). 1065–1081. 244 indexed citations

11.

Renaud, Justine, et al.. (2001). Cyclo‐oxygenase and lipoxygenase pathways in mast cell dependent‐neurogenic inflammation induced by electrical stimulation of the rat saphenous nerve. British Journal of Pharmacology. 132(7). 1581–1589. 32 indexed citations

12.

Carpentier, P., et al.. (1999). Respective role of lipoxygenase and nitric oxide‐synthase pathways in plasma histamine‐induced macromolecular leakage inconscious hamsters. British Journal of Pharmacology. 126(8). 1801–1809. 3 indexed citations

13.

Delaforge, M., et al.. (1999). The cyclo‐oxygenase‐dependent regulation of rabbit vein contraction: evidence for a prostaglandin E₂‐mediated relaxation. British Journal of Pharmacology. 126(1). 35–44. 5 indexed citations

14.

Carpentier, P., et al.. (1998). Histamine‐induced biphasic macromolecular leakage in the microcirculation of the conscious hamster: evidence for a delayed nitric oxide‐dependent leakage. British Journal of Pharmacology. 123(5). 943–951. 11 indexed citations

15.

Carpentier, P., et al.. (1998). l-Arginine and NG-nitro-l-arginine methyl ester cause macromolecule extravasation in the microcirculation of awake hamsters. European Journal of Pharmacology. 346(2-3). 275–282. 12 indexed citations

16.

Méry, Pierre‐François, Leif Hove‐Madsen, J. L. Mazet, Rémy Hanf, & Rodolphe Fischmeister. (1996). Binding constants determined from Ca2+ current responses to rapid applications and washouts of nifedipine in frog cardiac myocytes.. The Journal of Physiology. 494(1). 105–120. 21 indexed citations

17.

Hanf, Rémy, et al.. (1994). Differential effects of pertussis toxin on the muscarinic regulation of Ca2+ and K+ currents in frog cardiac myocytes.. The Journal of General Physiology. 104(5). 941–959. 13 indexed citations

18.

Hanf, Rémy, et al.. (1993). Agonist‐independent effects of muscarinic antagonists on Ca2+ and K+ currents in frog and rat cardiac cells.. The Journal of Physiology. 461(1). 743–765. 52 indexed citations

19.

Boutjdir, Mohamed, Pierre‐François Méry, Rémy Hanf, Alvin Shrier, & Rodolphe Fischmeister. (1990). High affinity forskolin inhibition of L-type Ca2+ current in cardiac cells.. Molecular Pharmacology. 38(6). 758–765. 26 indexed citations

20.

Hanf, Rémy, et al.. (1988). Rat cardiac hypertrophy Altered sodium‐calcium exchange activity in sarcolemmal vesicles. FEBS Letters. 236(1). 145–149. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact